Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-31

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved Upsher-Smith's generic cyclobenzaprine hydrochloride for use as a muscle relaxant in acute musculoskeletal conditions under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

ORIG AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)